JP2024539872A5 - - Google Patents
Info
- Publication number
- JP2024539872A5 JP2024539872A5 JP2024522407A JP2024522407A JP2024539872A5 JP 2024539872 A5 JP2024539872 A5 JP 2024539872A5 JP 2024522407 A JP2024522407 A JP 2024522407A JP 2024522407 A JP2024522407 A JP 2024522407A JP 2024539872 A5 JP2024539872 A5 JP 2024539872A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163263224P | 2021-10-28 | 2021-10-28 | |
| US63/263,224 | 2021-10-28 | ||
| PCT/US2022/048037 WO2023076485A1 (en) | 2021-10-28 | 2022-10-27 | Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539872A JP2024539872A (ja) | 2024-10-31 |
| JPWO2023076485A5 JPWO2023076485A5 (https=) | 2025-11-05 |
| JP2024539872A5 true JP2024539872A5 (https=) | 2025-11-05 |
Family
ID=86158503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522407A Pending JP2024539872A (ja) | 2021-10-28 | 2022-10-27 | Ｗｅｅ１阻害剤及びｄｎａ損傷応答（ｄｄｒ）阻害剤を含む併用療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240299395A1 (https=) |
| EP (1) | EP4422624A4 (https=) |
| JP (1) | JP2024539872A (https=) |
| CN (1) | CN118234493A (https=) |
| TW (1) | TW202333729A (https=) |
| WO (1) | WO2023076485A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020384291A1 (en) | 2019-11-15 | 2022-05-26 | Recurium Ip Holdings, Llc | Chiral synthesis of a tertiary alcohol |
| BR112023000350A2 (pt) | 2020-07-09 | 2023-03-28 | Recurium Ip Holdings Llc | Sais e formas de um inibidor de wee1 |
| WO2023217201A2 (zh) * | 2022-05-10 | 2023-11-16 | 杭州德睿智药科技有限公司 | 作为Wee1抑制剂的新型嘧啶并杂环类新化合物及其应用 |
| WO2025186213A1 (en) * | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
| WO2025193930A1 (en) * | 2024-03-14 | 2025-09-18 | Zeno Management, Inc. | Wee1 inhibitor combination therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2621857T3 (es) * | 2010-11-16 | 2017-07-05 | Array Biopharma, Inc. | Combinación de inhibidores de la cinasa 1 de punto de control e inhibidores de la cinasa WEE1 |
| EP2755482B1 (en) * | 2011-09-15 | 2016-06-01 | Merck Sharp & Dohme Corp. | Combination of mk-1775 and mk-8776 for treating cancer |
-
2022
- 2022-10-27 WO PCT/US2022/048037 patent/WO2023076485A1/en not_active Ceased
- 2022-10-27 CN CN202280066997.3A patent/CN118234493A/zh active Pending
- 2022-10-27 TW TW111140882A patent/TW202333729A/zh unknown
- 2022-10-27 EP EP22888179.3A patent/EP4422624A4/en active Pending
- 2022-10-27 JP JP2024522407A patent/JP2024539872A/ja active Pending
-
2024
- 2024-04-26 US US18/648,164 patent/US20240299395A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024539872A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2026000485A1 (es) | Composiciones de colorantes y saborizantes alimentarios que comprenden mioglobina microencapsulada. | |
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307045547S (https=) | ||
| BY13166U (https=) | ||
| CN307044269S (https=) | ||
| BY13135U (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| CN307044358S (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) |